Hetero launches generic breast cancer treatment drug in India

Drug firm Hetero Friday said it has launched generic Lapatinib tablets, used in the treatment of advanced or metastatic breast cancer in the country.

View in App
Agencies
The tablets are used in combination with Capecitabine or Letrozole, which together, inhibit the growth of cancer cells in patients, Hetero said.
New Delhi: Drug firm Hetero Friday said it has launched generic Lapatinib tablets, used in the treatment of advanced or metastatic breast cancer in the country. The tablets, under the brand name 'Hertab', have been launched in the strength of 250 mg, the company said.

The product is marketed and distributed by Hetero Healthcare Ltd and has been made available in two stock keeping units (SKUs), it added.

The tablets are used in combination with Capecitabine or Letrozole, which together, inhibit the growth of cancer cells in patients, Hetero said.


At present, the company has 36 manufacturing facilities worldwide and has presence in over 126 countries.
READ MORE
ADVERTISEMENT

READ MORE:

Sentiment Tracker

    You can select any three only
      Thank you for your responseThank you for your response

      LOGIN & CLAIM

      50 TIMESPOINTS

      ET Business Listings
      Generate Enquiries for your Business by Listing on Economictimes.com

      More from our Partners

      Loading next story
      Text Size:AAA
      Success
      This article has been saved

      *

      +